Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04538430 · ClinicalTrials.gov registry record · NA
Peripheral Nerve Stimulation for Back
A NA study, sponsored by University of Utah.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04538430: Clinical Trial NA study, sponsored by University of Utah.
NCT04538430 is a NA study that was terminated before completion, run by University of Utah. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04538430, a NA study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
To assess changes in pain, physical function, health-related quality of life, and cost-effectiveness in patients with low back pain, without symptoms of radiculopathy, that have not responded to conservative or traditional interventional measures and are having a SPRINT percutaneous peripheral nerve stimulator placed as standard of care. Patients will be assessed periodically (by questionnaire) after the placement of the SPRINT, FDA approved 60 day, percutaneous peripheral nerve stimulator, targeting the bilateral medial branches at the suspected level of pain generation. Neither the manufacturer nor the FDA are involved or will have access to data from this study.
Primary Outcome
Assessment of Pain Numeric Rating Scale (0-10) response after placement of SPRINT percutaneous peripheral nerve stimulator for chronic low back pain. 0 being no pain and 10 being the worst pain.
Interventions
- DEVICE SPRINT percutaneous peripheral nerve stimulator placed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-11-22 |
| Est. Completion | 2021-09-09 |
| Phase | NA |
Why NCT04538430 stopped before completion
NCT04538430 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which SPRINT percutaneous peripheral nerve stimulator placed is the first listed.
NCT04538430 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04538430 about?
NCT04538430 is a clinical study titled "Peripheral Nerve Stimulation for Back". To assess changes in pain, physical function, health-related quality of life, and cost-effectiveness in patients with low back pain, without symptoms of radiculopathy, that have not responded to conservative or traditional interventional measures and are having a SPRINT percutaneous peripheral nerve...
What is the current status of trial NCT04538430?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2019-11-22. Estimated completion is 2021-09-09.
What interventions are being tested in trial NCT04538430?
The interventions under investigation include: SPRINT percutaneous peripheral nerve stimulator placed (DEVICE).
Who is sponsoring clinical trial NCT04538430?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04538430's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI